243 related articles for article (PubMed ID: 30284925)
1. TAILS proteomics reveals dynamic changes in airway proteolysis controlling protease activity and innate immunity during COPD exacerbations.
Mallia-Milanes B; Dufour A; Philp C; Solis N; Klein T; Fischer M; Bolton CE; Shapiro S; Overall CM; Johnson SR
Am J Physiol Lung Cell Mol Physiol; 2018 Dec; 315(6):L1003-L1014. PubMed ID: 30284925
[TBL] [Abstract][Full Text] [Related]
2. Moraxella catarrhalis acquisition, airway inflammation and protease-antiprotease balance in chronic obstructive pulmonary disease.
Parameswaran GI; Wrona CT; Murphy TF; Sethi S
BMC Infect Dis; 2009 Nov; 9():178. PubMed ID: 19912665
[TBL] [Abstract][Full Text] [Related]
3. Altered protease and antiprotease balance during a COPD exacerbation contributes to mucus obstruction.
Chillappagari S; Preuss J; Licht S; Müller C; Mahavadi P; Sarode G; Vogelmeier C; Guenther A; Nahrlich L; Rubin BK; Henke MO
Respir Res; 2015 Jul; 16(1):85. PubMed ID: 26169056
[TBL] [Abstract][Full Text] [Related]
4. Progranulin is a substrate for neutrophil-elastase and proteinase-3 in the airway and its concentration correlates with mediators of airway inflammation in COPD.
Ungurs MJ; Sinden NJ; Stockley RA
Am J Physiol Lung Cell Mol Physiol; 2014 Jan; 306(1):L80-7. PubMed ID: 24186875
[TBL] [Abstract][Full Text] [Related]
5. Discrimination of Methionine Sulfoxide and Sulfone by Human Neutrophil Elastase.
Leahy D; Grant C; Jackson A; Duff A; Tardiota N; Van Haeften J; Chen X; Peake JM; Kruppa MD; Smith ET; Johnson DA; Lott WB; Harris JM
Molecules; 2021 Sep; 26(17):. PubMed ID: 34500777
[TBL] [Abstract][Full Text] [Related]
6. Midkine is expressed and differentially processed during chronic obstructive pulmonary disease exacerbations and ventilator-associated pneumonia associated with Staphylococcus aureus infection.
Linge HM; Andersson C; Nordin SL; Olin AI; Petersson AC; Mörgelin M; Welin A; Bylund J; Bjermer L; Erjefält J; Egesten A
Mol Med; 2013 Sep; 19(1):314-23. PubMed ID: 24043271
[TBL] [Abstract][Full Text] [Related]
7. Antiviral immunity is impaired in COPD patients with frequent exacerbations.
Singanayagam A; Loo SL; Calderazzo M; Finney LJ; Trujillo Torralbo MB; Bakhsoliani E; Girkin J; Veerati P; Pathinayake PS; Nichol KS; Reid A; Footitt J; Wark PAB; Grainge CL; Johnston SL; Bartlett NW; Mallia P
Am J Physiol Lung Cell Mol Physiol; 2019 Dec; 317(6):L893-L903. PubMed ID: 31513433
[TBL] [Abstract][Full Text] [Related]
8. Protease-antiprotease imbalances differ between Cystic Fibrosis patients' upper and lower airway secretions.
Hentschel J; Fischer N; Janhsen WK; Markert UR; Lehmann T; Sonnemann J; Böer K; Pfister W; Hipler UC; Mainz JG
J Cyst Fibros; 2015 May; 14(3):324-33. PubMed ID: 25286826
[TBL] [Abstract][Full Text] [Related]
9. The effect of azithromycin in adults with stable neutrophilic COPD: a double blind randomised, placebo controlled trial.
Simpson JL; Powell H; Baines KJ; Milne D; Coxson HO; Hansbro PM; Gibson PG
PLoS One; 2014; 9(8):e105609. PubMed ID: 25148049
[TBL] [Abstract][Full Text] [Related]
10. Role of airway glucose in bacterial infections in patients with chronic obstructive pulmonary disease.
Mallia P; Webber J; Gill SK; Trujillo-Torralbo MB; Calderazzo MA; Finney L; Bakhsoliani E; Farne H; Singanayagam A; Footitt J; Hewitt R; Kebadze T; Aniscenko J; Padmanaban V; Molyneaux PL; Adcock IM; Barnes PJ; Ito K; Elkin SL; Kon OM; Cookson WO; Moffat MF; Johnston SL; Tregoning JS
J Allergy Clin Immunol; 2018 Sep; 142(3):815-823.e6. PubMed ID: 29310905
[TBL] [Abstract][Full Text] [Related]
11. Proteases: Pivot Points in Functional Proteomics.
Verhamme IM; Leonard SE; Perkins RC
Methods Mol Biol; 2019; 1871():313-392. PubMed ID: 30276748
[TBL] [Abstract][Full Text] [Related]
12. Systemic signs of neutrophil mobilization during clinically stable periods and during exacerbations in smokers with obstructive pulmonary disease.
Andelid K; Andersson A; Yoshihara S; Åhrén C; Jirholt P; Ekberg-Jansson A; Lindén A
Int J Chron Obstruct Pulmon Dis; 2015; 10():1253-63. PubMed ID: 26170654
[TBL] [Abstract][Full Text] [Related]
13. N-Terminomics/TAILS Profiling of Proteases and Their Substrates in Ulcerative Colitis.
Gordon MH; Anowai A; Young D; Das N; Campden RI; Sekhon H; Myers Z; Mainoli B; Chopra S; Thuy-Boun PS; Kizhakkedathu J; Bindra G; Jijon HB; Heitman S; Yates R; Wolan DW; Edgington-Mitchell LE; MacNaughton WK; Dufour A
ACS Chem Biol; 2019 Nov; 14(11):2471-2483. PubMed ID: 31393699
[TBL] [Abstract][Full Text] [Related]
14. Proteases essential for human influenza virus entry into cells and their inhibitors as potential therapeutic agents.
Kido H; Okumura Y; Yamada H; Le TQ; Yano M
Curr Pharm Des; 2007; 13(4):405-14. PubMed ID: 17311557
[TBL] [Abstract][Full Text] [Related]
15. Hypoxia Increases the Potential for Neutrophil-mediated Endothelial Damage in Chronic Obstructive Pulmonary Disease.
Lodge KM; Vassallo A; Liu B; Long M; Tong Z; Newby PR; Agha-Jaffar D; Paschalaki K; Green CE; Belchamber KBR; Ridger VC; Stockley RA; Sapey E; Summers C; Cowburn AS; Chilvers ER; Li W; Condliffe AM
Am J Respir Crit Care Med; 2022 Apr; 205(8):903-916. PubMed ID: 35044899
[No Abstract] [Full Text] [Related]
16. Innate immune responses are increased in chronic obstructive pulmonary disease.
Baines KJ; Simpson JL; Gibson PG
PLoS One; 2011 Mar; 6(3):e18426. PubMed ID: 21483784
[TBL] [Abstract][Full Text] [Related]
17. Rhinovirus infection induces degradation of antimicrobial peptides and secondary bacterial infection in chronic obstructive pulmonary disease.
Mallia P; Footitt J; Sotero R; Jepson A; Contoli M; Trujillo-Torralbo MB; Kebadze T; Aniscenko J; Oleszkiewicz G; Gray K; Message SD; Ito K; Barnes PJ; Adcock IM; Papi A; Stanciu LA; Elkin SL; Kon OM; Johnson M; Johnston SL
Am J Respir Crit Care Med; 2012 Dec; 186(11):1117-24. PubMed ID: 23024024
[TBL] [Abstract][Full Text] [Related]
18. Identification of Protease Cleavage Sites and Substrates in Cancer by Carboxy-TAILS (C-TAILS).
Solis N; Overall CM
Methods Mol Biol; 2018; 1731():15-28. PubMed ID: 29318539
[TBL] [Abstract][Full Text] [Related]
19. Neutrophil proteases alter the interleukin-22-receptor-dependent lung antimicrobial defence.
Guillon A; Jouan Y; Brea D; Gueugnon F; Dalloneau E; Baranek T; Henry C; Morello E; Renauld JC; Pichavant M; Gosset P; Courty Y; Diot P; Si-Tahar M
Eur Respir J; 2015 Sep; 46(3):771-82. PubMed ID: 26250498
[TBL] [Abstract][Full Text] [Related]
20. Neutrophil extracellular traps are associated with disease severity and microbiota diversity in patients with chronic obstructive pulmonary disease.
Dicker AJ; Crichton ML; Pumphrey EG; Cassidy AJ; Suarez-Cuartin G; Sibila O; Furrie E; Fong CJ; Ibrahim W; Brady G; Einarsson GG; Elborn JS; Schembri S; Marshall SE; Palmer CNA; Chalmers JD
J Allergy Clin Immunol; 2018 Jan; 141(1):117-127. PubMed ID: 28506850
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
